[Cerebral monoamines and evoked activity in the centrum medianum of the thalamus and in the primary somatic cortical area].
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000588:Amines / Q000378:metabolism*; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001143:Arousal; D001923:Brain Chemistry; D002415:Cats; D002540:Cerebral Cortex / Q000187:drug effects*; D004357:Drug Synergism; D004558:Electric Stimulation; D005071:Evoked Potentials / Q000187:drug effects*; D007274:Injections, Intraperitoneal; D008750:Methyldopa / Q000494:pharmacology; D009526:Nialamide / Q000494:pharmacology; D010649:Phenylalanine / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D012894:Sleep Stages; D013788:Thalamus / Q000187:drug effects*
D000588:Amines; D010649:Phenylalanine; D008750:Methyldopa; D012110:Reserpine; D006916:5-Hydroxytryptophan; D000661:Amphetamine; D009526:Nialamide
Monoamines cerebrales et activites evoquees au niveau du centre median du thalamus et de l'aire corticale somatique primaire.